FDA clears prasugrel, requires black-box warning

07/12/2009 | Bloomberg

The FDA approved prasugrel, an anti-clotting drug from Daiichi Sankyo and Eli Lilly. The product will be launched under the brand name Effient and carry a black-box warning about an increased risk of potentially fatal bleeding.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA